Anti-apoptosis gene, survivin, and prognosis of neuroblastoma

Lancet

Volumn 351, Issue 9106, 1998, Pages 882-883

  Adida, Colette ^b   Berrebi, Dominique ^b   Peuchmaur, Michael ^b   Reyes Mugica, Miguel ^b   Altieri, Dario C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

APOPTOSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIGENE FAMILY; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY;

EID: 0032554527     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)70294-4     Document Type: Article

References (5)

1. 1 Pritchard J, Hickman JA. Why does stage 4s neuroblastoma regress spontaneously? Lancet 1994; 344: 869-70.
2. 2 Castle VP, Heidelberger KP, Bromberg J, Ou X, Dole M, Nunez G. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavourable histology and N-myc amplification. Am J Pathol 1993; 143: 1543-50.
3. 3 Hoehner JC, Hedborg F, Wiklund HJ, Olsen L, Pahlman S. Cellular death in neuroblastoma: In situ correlation of apoptosis and bcl-2 expression. Int J Cancer 1995; 62: 19-24.
4. 4 Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917-21.
5. 5 Hikeda H, Hirato J, Akami M, et al. Bcl-2 oncoprotein expression and apoptosis in neuroblastoma. J Pediatr Surg 1995; 30: 805-08.